VeriMom¿Es decursinol seguro durante el embarazo?
No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
Related ingredients
Frequently asked questions
- ¿Es decursinol seguro durante el embarazo?
- No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- ¿Es decursinol seguro durante la lactancia?
- No data were found showing transfer into milk, human lactation exposure, or reproductive classification for decursinol. No regulatory (CIR/SCCS/harmonised CLP) guidance or clinical reports were identified to indicate a breastfeeding hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- ¿Es decursinol seguro para la piel del bebé?
- No infant‑specific safety or dermal‑absorption studies were located. Adult topical cosmetic exposure literature/regulatory sources are absent; because decursinol is a small lipophilic coumarin derivative with measurable bioactivity and dermal use in research contexts, neonatal/infant skin exposure is conservatively assigned higher exposure (+1) due to immature barrier and higher surface‑area:weight; no evidence was found to increase hazard or mechanism scores for infants. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19228635/?utm_source=openai))
- ¿Cómo puntúa VeriMom a decursinol?
- VeriMom puntúa decursinol en 87/100 (riesgo bajo) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a decursinol en el embarazo?
- Consulta nuestra lista de alternativas seguras a decursinol según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.